Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00530894 · ClinicalTrials.gov registry record · NA
THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 1,057
- Enrollment target
NCT00530894 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 1,057 participants.
The verdict
NCT00530894, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,057 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of the device and delivery systems (transfemoral and transapical) in high risk, symptomatic patients with severe aortic stenosis.
Interventions
- DEVICE Edwards SAPIEN Transcatheter Heart Valve
- DEVICE Surgical Valve Replacement
- OTHER medical management and/or balloon aortic valvuloplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,057 participants |
| Start Date | 2007-04 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00530894
The ClinicalTrials.gov registry entry for NCT00530894 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,057 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Edwards SAPIEN Transcatheter Heart Valve is the first listed.
NCT00530894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00530894 about?
NCT00530894 is a clinical study titled "THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial". The purpose of this study is to determine the safety and effectiveness of the device and delivery systems (transfemoral and transapical) in high risk, symptomatic patients with severe aortic stenosis.
What is the current status of trial NCT00530894?
This trial is currently completed. It is a NA study. The enrollment target is 1,057 participants. The study started on 2007-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT00530894?
The interventions under investigation include: Edwards SAPIEN Transcatheter Heart Valve (DEVICE), Surgical Valve Replacement (DEVICE), medical management and/or balloon aortic valvuloplasty (OTHER).
Who is sponsoring clinical trial NCT00530894?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.